Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1729427 · CNSP

CNS Pharmaceuticals, Inc.

Filing with the SEC SEC-reporting company Houston, TX Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $16K for the year (2024: −$15K).
  • Private capital raiseOn May 19, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$16K−$15K
Total assets$8.6M$8.7M
Total liabilities$4.1M$2.5M
Stockholders’ equity$4.5M$6.2M
Cash and equivalents$7.2M$6.5M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
CNS Pharmaceuticals, Inc.
CIK
0001729427
Tickers
CNSP
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Nevada
Business address
Houston, Texas
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 2, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Director or officer change: Director or officer change
    Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 2, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 12, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed May 19, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 9.01 · filed May 4, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 31, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Mar 2, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Feb 17, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Dec 17, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Nov 21, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 15, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed May 14, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Apr 14, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 31, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 18, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 14, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Aug 2, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 24, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 12, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 10, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 16, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed May 3, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Apr 1, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 1, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 3.01, 5.02 · filed Feb 27, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 5.02 · filed Feb 27, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Feb 21, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 9.01 · filed Feb 2, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jan 31, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 23, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 8, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 15, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Aug 18, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 15, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed May 8, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 31, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 3, 2023 · filing